Reuters logo
BRIEF-Jaguar Animal Health enters binding agreement of terms to merge with Napo Pharmaceuticals
February 8, 2017 / 11:40 PM / 7 months ago

BRIEF-Jaguar Animal Health enters binding agreement of terms to merge with Napo Pharmaceuticals

Feb 8 (Reuters) - Jaguar Animal Health Inc

* Press Release - Jaguar Animal Health enters binding agreement of terms to merge with Napo Pharmaceuticals

* Jaguar Animal Health -Transaction approved by unanimous vote of independent and disinterested members of each of Jaguar’s and Napo’s board of directors

* Jaguar Animal Health - Binding financial terms of merger include a 3-to-1 Napo-to-Jaguar value ratio to calculate relative ownership of combined entity

* Jaguar Animal Health Inc- Napo will operate as a wholly-owned subsidiary of Jaguar, focused on human health

* Jaguar Animal Health Inc says as of January 31, 2017, Napo owned about 19% of jaguar’s outstanding shares of common stock

* Jaguar Animal-Terms of merger include provisions that Napo’s secured convertible debt shall not exceed $10 million, unsecured debt shall not exceed $3 million

* Jaguar Animal - Third party will invest $3.0 million in Jaguar for approximately four million shares of newly issued common stock of Jaguar Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below